Enhancing strategies for COVID-19 solutions in diagnosis, vaccine development and therapies
With the advancement in biomedical research, physicians and scientists have been using technologies to understand the mechanism of action of SARS-CoV-2. Through the understanding on the interaction of the Receptor Binding Domain (RBD) in the spike protein located on the viral coat, with the angiotensin converting enzyme-2 (ACE2) receptor on human cells, we have successfully developed vaccines and monoclonal antibody therapies that can more specifically target SARS-CoV2. In addition, the advancement in scientific technologies to trace the spread and the development of various mutant strains allow us to quickly respond and provide solutions for accurate diagnosis, vaccines and therapies development. As such, a good understanding and connection to the technologies available to develop the vaccines, therapies and diagnosis kits are crucial in navigating out of the pandemic.
In this webinar, you will learn:
1. The available platforms or systems for us to study the mechanism of action of COVID-19 and the immune responses it triggers
2. How to discover and produce potential COVID-19 antibody treatment in a high throughput manner
3. The development of diagnostic tools for COVID-19